No Correction, No Retraction, No Apology, No Comment: Paroxetine Trial Reanalysis Raises Questions About Institutional Responsibility

MeSH terms

• Antidepressive Agents, Second-Generation / therapeutic use
• Clinical Trials as Topic* / ethics
• Clinical Trials as Topic* / legislation & jurisprudence
• Clinical Trials as Topic* / standards
• Depressive Disorder, Major / drug therapy
• Humans
• Paroxetine / therapeutic use
• Reproducibility of Results*
• Retraction of Publication as Topic
• United States
• Universities